Thymulin — Clinical Reference

**⚠ Educational reference only — not medical advice.** This article is for research and educational reference. Always consult your own physician before considering any peptide protocol. See the full Disclaimer at the end of this article. ## Introduction Thymulin is a nonapeptide thymic factor whose biological activity is strictly dependent on its association with a zinc ion. Originally characterized in the Dardenne and Bach laboratory in the 1970s as one of several thymic peptide hormones implicated in T-cell maturation. Investigational; no broadly approved clinical indication. ## Mechanism of Action The zinc-bound form (Zn-thymulin) is the active species and binds receptors on T-lymphocytes, modulating maturation, cytokine secretion, and the balance between regulatory and effector T-cell populations. Activity is gated by available zinc; serum thymulin activity is sensitive to zinc status, and zinc deficiency reduces bioactivity even when peptide concentrations are intact. ## Research Indications Age-related immune decline (thymulin levels fall with age), autoimmune disease, allergic disease, infection susceptibility in immunocompromised populations, adjunctive immune-supportive protocols. ## Reconstitution Typical 5 mg lyophilized vial: add **2.5 mL of bacteriostatic water**, swirl gently. Final concentration **2000 mcg/mL (2 mg/mL)** — each 0.05 mL (5 units on a U-100 insulin syringe) delivers 100 mcg. **Ensure adequate dietary or supplemental zinc** during use, as the zinc-bound form is the active species. ## Dosing Protocol (research literature) Research protocols typically dose **100–1000 mcg subcutaneously once daily** for **8–16 weeks** with reassessment. Some immune-support protocols use 5 days on / 2 days off rather than continuous daily dosing. ## Administration Subcutaneous into abdominal fat, rotating sites. ## Storage & Handling Lyophilized: refrigerate (2–8°C); freeze (–20°C) for long-term storage. Reconstituted: refrigerate; stable approximately **14–21 days**. Protect from light. ## Side Effects Generally well-tolerated in available reports, with adverse effects predominantly mild injection-site reactions. Long-term safety data are limited. ## Contraindications Pregnancy, lactation, active autoimmune flare without specialist input. ## Monitoring Baseline CBC with differential, serum zinc, and an indication-appropriate immunologic instrument or marker. Re-measure at 8 and 16 weeks. ## Disclaimer **This article is for informational and research-reference purposes only.** Nothing in this document constitutes medical advice, a prescription, or a recommendation from a physician. The reconstitution, dosing, and protocol information above reflects ranges commonly cited in published research and clinician-directed protocols — it is provided as reference material only, not as instructions, an endorsement of off-label use, or a substitute for individualized medical evaluation. **Customers should do their own research and consult their own physician** before considering any peptide protocol. Whether a given compound is appropriate for an individual — and at what dose, for what duration, and alongside what monitoring — is a decision that only a licensed clinician with knowledge of that individual's medical history, current medications, and conditions can make. The platform and the author make no claim that any compound described here is safe, effective, or appropriate for any particular person or purpose, and accept no responsibility for outcomes arising from self-directed use of the information.